UCB - Ebit

Stock Price
270.20
Daily Change
-5.90 -2.14%
Monthly
4.32%
Yearly
48.38%
Q1 Forecast
269.39

UCB reported EUR502M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Alcon AG USD 334M 84M Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
Amarin USD -1.7M 8.47M Sep/2025
argenx SE USD 349.97M 61.94M Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bayer EUR -399M 363M Sep/2025
Galapagos EUR -41.67M 15.35M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.21B 180M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Orion EUR 328.1M 207.1M Dec/2025
Recordati EUR 278.23M 112.58M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 502M 168M Dec/2024
Unibail Rodamco EUR 1.13B 41.8M Dec/2024